Yi Zong

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Signaling Pathway

Top Venues

Diabetes, metabolic syndrome and obesity : targets and therapy

International journal of endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Zong, Weihua Yu, Hanghang Hong, Zhiqiang Zhu, Wenbo Xiao, Kewu Wang, Guoqiang Xu
Ginsenoside Rg1 Improves Inflammation and Autophagy of the Pancreas and Spleen in Streptozotocin-Induced Type 1 Diabetic Mice. International journal of endocrinology 2023 (2023)
Jin Chen, Guoping Zhu, Wenbo Xiao, Xiaosong Huang, Kewu Wang, Yi Zong
Ginsenoside Rg1 Ameliorates Pancreatic Injuries via the AMPK/mTOR Pathway in vivo and in vitro. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Jin Chen, Guoping Zhu, Wenbo Xiao, Xiaosong Huang, Kewu Wang, Yi Zong
Ginsenoside Rg1 Ameliorates Pancreatic Injuries via the AMPK/mTOR Pathway in vivo and in vitro. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Yi Zong, Weihua Yu, Hanghang Hong, Zhiqiang Zhu, Wenbo Xiao, Kewu Wang, Guoqiang Xu
Ginsenoside Rg1 Improves Inflammation and Autophagy of the Pancreas and Spleen in Streptozotocin-Induced Type 1 Diabetic Mice. International journal of endocrinology 2023 (2023)